Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

De-escalation of Treatment in Metastatic Renal Cell Carcinoma: Why? How? Who? When?

Clinical genitourinary cancer·2026

Same author

Novel Chitosan Bioink Derived from <i>Eurycantha calcarata</i> (Lucas, 1869) for 3D Bioprinting of Cell-Compatible Scaffolds.

ACS omega·2026

Same author

Papillary renal cell carcinoma - exploratory results of the SUNNIFORECAST trial comparing Ipilimumab plus Nivolumab vs standard of care as first line therapy based on central pathological review.

European journal of cancer (Oxford, England : 1990)·2026

Same author

Spontaneous Regression of Clear Cell Renal Cell Carcinoma Metastases or Immune Restoration?

Current oncology (Toronto, Ont.)·2026

Same author

Neoadjuvant Durvalumab ± Tremelimumab in Combination With Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Muscle-Invasive Bladder Carcinoma: Results of the Phase I/II NEMIO Study.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026

Same author

Real-world efficacy and safety of immune checkpoint blockades in advanced urothelial carcinoma with histologic variant subtypes: the pembroblad study.

Cancer immunology, immunotherapy : CII·2026

Search research articles

Related Experiment Video

Updated: May 28, 2026

Synthesis and Characterization of Placental Chondroitin Sulfate A (plCSA)-Targeting Lipid-Polymer Nanoparticles

Synthesis and Characterization of Placental Chondroitin Sulfate A (plCSA)-Targeting Lipid-Polymer Nanoparticles

Published on: September 18, 2018

Nucleoside-lipid-based nanoparticles for cisplatin delivery.

Salim Khiati¹, Delphine Luvino, Khalid Oumzil

¹INSERM U869, Bordeaux F-33076, France.

|October 4, 2011

Summary

Researchers developed novel hybrid nucleoside-lipids for efficient cisplatin delivery. These nanoparticles target tumors, improving anticancer drug efficacy and reducing toxicity.

More Related Videos

Custom-designed Laser-based Heating Apparatus for Triggered Release of Cisplatin from Thermosensitive Liposomes with Magnetic Resonance Image Guidance

Custom-designed Laser-based Heating Apparatus for Triggered Release of Cisplatin from Thermosensitive Liposomes with Magnetic Resonance Image Guidance

Published on: December 13, 2015

A Tripeptide-Stabilized Nanoemulsion of Oleic Acid

A Tripeptide-Stabilized Nanoemulsion of Oleic Acid

Published on: February 27, 2019

Related Experiment Videos

Last Updated: May 28, 2026

Synthesis and Characterization of Placental Chondroitin Sulfate A (plCSA)-Targeting Lipid-Polymer Nanoparticles

Synthesis and Characterization of Placental Chondroitin Sulfate A (plCSA)-Targeting Lipid-Polymer Nanoparticles

Published on: September 18, 2018

Custom-designed Laser-based Heating Apparatus for Triggered Release of Cisplatin from Thermosensitive Liposomes with Magnetic Resonance Image Guidance

Custom-designed Laser-based Heating Apparatus for Triggered Release of Cisplatin from Thermosensitive Liposomes with Magnetic Resonance Image Guidance

Published on: December 13, 2015

A Tripeptide-Stabilized Nanoemulsion of Oleic Acid

A Tripeptide-Stabilized Nanoemulsion of Oleic Acid

Published on: February 27, 2019

Area of Science:

Biomedical Engineering
Nanotechnology
Drug Delivery

Background:

Selective delivery of anticancer agents to tumors is crucial for improving efficacy and reducing toxicity.
Existing drug delivery systems face limitations in efficiency and overcoming drug resistance.

Purpose of the Study:

To develop a novel drug delivery system for enhanced cisplatin delivery.
To create stable nanoparticles using hybrid nucleoside-lipids for targeted cancer therapy.

Main Methods:

Synthesis of hybrid nucleoside-lipids.
Characterization of self-assembled nanoparticle formation and cisplatin encapsulation.
Evaluation of nanoparticle delivery and efficacy in sensitive and resistant cancer cell lines.

Main Results:

Hybrid nucleoside-lipids self-assemble into stable nanoparticles with high cisplatin loading.
Nanoparticles efficiently deliver cisplatin into various cancer cell lines, including resistant ones.
The developed system overcomes limitations of previous cisplatin delivery methods.

Conclusions:

Hybrid nucleoside-lipids represent a promising platform for developing advanced nanoparticle-based drug delivery systems.
This novel approach offers a potential strategy to improve the therapeutic index of cisplatin in cancer treatment.
The self-assembling properties of nucleoside-lipids enable the creation of effective and stable anticancer nanocarriers.